Physician profile
Sherri Beth Morrison
NPI 1285738500
$4,908.60
in general payments reported to CMS, 2019-2025
32 companies · $529 in 2025
The $529 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $968 · 2022: $964 · 2023: $1,268 · 2024: $1,180 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,746 · Education: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,746.11 |
| Education | $230.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $956.96 | 2021-2024 | Xarelto |
| Endologix LLC | $939.12 | 2021-2025 | Alto Abdominal Stent Graft System, Torus Stent Graft System, Endocross Device |
| Medtronic, INC. | $469.49 | 2021-2023 | In.Pact Admiral |
| Kerecis Limited | $380.43 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Surmodics, INC. | $366.80 | 2023-2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Novartis Pharmaceuticals Corporation | $284.15 | 2022-2025 | |
| Medical Device Business Services, INC. | $260.78 | 2023-2024 | Stratafix, Vistaseal, Evarrest |
| Novo Nordisk INC | $176.78 | 2025 | Ozempic, Wegovy |
| Actelion Pharmaceuticals US, INC. | $163.44 | 2023 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $101.16 | 2023-2024 | Tagrisso, Farxiga |
| Smith+Nephew, INC. | $87.16 | 2024-2025 | Collagenase Santyl, Grafix |
| Penumbra, INC. | $69.64 | 2022 | |
| Lemaitre Vascular, INC. | $68.31 | 2025 | Artegraft Vascular Graft, Xenosure Biologic Patch |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.47 | 2023-2024 | Jardiance |
| Arthrex, INC. | $59.54 | 2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $55.03 | 2021-2025 | |
| Organogenesis INC. | $45.30 | 2024 | |
| Urgo Medical North America, LLC | $42.11 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Kiniksa Pharmaceuticals, LTD. | $38.37 | 2023 | Arcalyst |
| Merck Sharp & Dohme LLC | $31.55 | 2025 | Verquvo |
| Silk Road Medical, INC. | $27.51 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $26.81 | 2021 | |
| Convatec INC. | $26.40 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $22.63 | 2023 | Eliquis |
| Inspire Medical Systems, INC. | $22.28 | 2024 | Inspire |
| Atricure, INC. | $21.32 | 2024 | |
| Aroa Biosurgery Incorporated | $20.70 | 2023 | |
| Becton, Dickinson and Company | $20.70 | 2024 | Denali Vena Cava Filter |
| Olympus America INC. | $15.36 | 2025 | Itind System |
| Cardiva Medical, INC. | $14.97 | 2022 | |
| Cook Medical LLC | $14.72 | 2021 | |
| United Therapeutics Corporation | $14.61 | 2025 | Tyvaso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherri Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.